{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:16Z","timestamp":1740134836073,"version":"3.37.3"},"reference-count":9,"publisher":"American Society of Hematology","issue":"10","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9,8]]},"DOI":"10.1182\/blood.2022017447","type":"journal-article","created":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:34:14Z","timestamp":1662651254000},"page":"1053-1054","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":0,"title":["Radiotherapy is here to stay"],"prefix":"10.1182","volume":"140","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4182-9355","authenticated-orcid":false,"given":"Jamie E.","family":"Flerlage","sequence":"first","affiliation":[{"name":"St. Jude Children\u2019s Research Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"issue":"10","key":"2022090815331503400_B1","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1182\/blood.2022016098","article-title":"Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis","volume":"140","author":"Parekh","journal-title":"Blood."},{"author":"Charlier","key":"2022090815331503400_B2"},{"issue":"15","key":"2022090815331503400_B3","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1002\/cncr.31519","article-title":"Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: a report from the Children\u2019s Oncology Group","volume":"124","author":"Keller","year":"2018","journal-title":"Cancer."},{"issue":"14","key":"2022090815331503400_B4","doi-asserted-by":"crossref","first-page":"4241","DOI":"10.1182\/bloodadvances.2022007363","article-title":"A real-world study of combined modality therapy for early-stage Hodgkin lymphoma: too little treatment impacts outcome","volume":"6","author":"Chohan","year":"2022","journal-title":"Blood Adv."},{"issue":"16","key":"2022090815331503400_B5","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1200\/JCO.2016.68.6394","article-title":"Early positron emission tomography response-adapted treatment in stage I and II Hodgkin lymphoma: final results of the randomized EORTC\/LYSA\/FIL H10 trial","volume":"35","author":"Andr\u00e9","year":"2017","journal-title":"J Clin Oncol."},{"issue":"31","key":"2022090815331503400_B6","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1200\/JCO.19.00964","article-title":"Positron emission tomography-guided treatment in early-stage favorable Hodgkin lymphoma: final results of the international, randomized phase III HD16 trial by the German Hodgkin Study Group","volume":"37","author":"Fuchs","year":"2019","journal-title":"J Clin Oncol."},{"issue":"3","key":"2022090815331503400_B7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1200\/JCO.2006.08.4772","article-title":"Final results of a prospective clinical trial with VAMP and low-dose involved-field radiation for children with low-risk Hodgkin\u2019s disease","volume":"25","author":"Donaldson","year":"2007","journal-title":"J Clin Oncol."},{"issue":"32","key":"2022090815331503400_B8","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1200\/JCO.2013.52.5410","article-title":"Dose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children\u2019s Oncology Group Study AHOD0031","volume":"32","author":"Friedman","year":"2014","journal-title":"J Clin Oncol."},{"issue":"1","key":"2022090815331503400_B9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S1470-2045(21)00470-8","article-title":"Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial","volume":"23","author":"Mauz-K\u00f6rholz","year":"2022","journal-title":"Lancet Oncol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/10\/1053\/1919015\/bloodbld2022017447c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/blood\/article-pdf\/140\/10\/1053\/1919015\/bloodbld2022017447c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T15:34:26Z","timestamp":1662651266000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/140\/10\/1053\/486477\/Radiotherapy-is-here-to-stay"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,8]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,9,8]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2022017447","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2022,9,8]]}}}